Do postliver transplant patients need thromboprophylactic anticoagulation?

Amar Nath Mukerji, Andreas Karachristos, Manoj Maloo, David Johnson, Ashokkumar Jain

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Postoperative thromboprophylactic anticoagulation against Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) is standard of care with current evidence-based guidelines. However, majority of liver transplant (LT) patients have thrombocytopenia and/or prolonged INR before surgery. Studies or guidelines regarding role of prophylactic anticoagulation after LT are lacking. There is a need to balance the risk of thrombosis with significant hemorrhage, implying those needing transfusion or return to OR due to bleeding. We conclude that after LT, anticoagulation is not required routinely for DVT/PE prophylaxis. Rather, it is indicated in specific circumstances, chiefly for prophylaxis of hepatic artery thrombosis or portal vein thrombosis in cases with use of grafts, pediatric cases, small size vessels, Budd Chiari syndrome, amongst others.

Original languageEnglish (US)
Pages (from-to)673-677
Number of pages5
JournalClinical and Applied Thrombosis/Hemostasis
Volume20
Issue number7
DOIs
StatePublished - Jan 1 2014

Fingerprint

Transplants
Thrombosis
Pulmonary Embolism
Venous Thrombosis
Liver
Guidelines
Hemorrhage
Budd-Chiari Syndrome
International Normalized Ratio
Hepatic Artery
Standard of Care
Portal Vein
Thrombocytopenia
Pediatrics

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Mukerji, Amar Nath ; Karachristos, Andreas ; Maloo, Manoj ; Johnson, David ; Jain, Ashokkumar. / Do postliver transplant patients need thromboprophylactic anticoagulation?. In: Clinical and Applied Thrombosis/Hemostasis. 2014 ; Vol. 20, No. 7. pp. 673-677.
@article{c4dd56592fcd4465973caf3fcdbfc7d4,
title = "Do postliver transplant patients need thromboprophylactic anticoagulation?",
abstract = "Postoperative thromboprophylactic anticoagulation against Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) is standard of care with current evidence-based guidelines. However, majority of liver transplant (LT) patients have thrombocytopenia and/or prolonged INR before surgery. Studies or guidelines regarding role of prophylactic anticoagulation after LT are lacking. There is a need to balance the risk of thrombosis with significant hemorrhage, implying those needing transfusion or return to OR due to bleeding. We conclude that after LT, anticoagulation is not required routinely for DVT/PE prophylaxis. Rather, it is indicated in specific circumstances, chiefly for prophylaxis of hepatic artery thrombosis or portal vein thrombosis in cases with use of grafts, pediatric cases, small size vessels, Budd Chiari syndrome, amongst others.",
author = "Mukerji, {Amar Nath} and Andreas Karachristos and Manoj Maloo and David Johnson and Ashokkumar Jain",
year = "2014",
month = "1",
day = "1",
doi = "10.1177/1076029614538490",
language = "English (US)",
volume = "20",
pages = "673--677",
journal = "Clinical and Applied Thrombosis/Hemostasis",
issn = "1076-0296",
publisher = "SAGE Publications Inc.",
number = "7",

}

Do postliver transplant patients need thromboprophylactic anticoagulation? / Mukerji, Amar Nath; Karachristos, Andreas; Maloo, Manoj; Johnson, David; Jain, Ashokkumar.

In: Clinical and Applied Thrombosis/Hemostasis, Vol. 20, No. 7, 01.01.2014, p. 673-677.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Do postliver transplant patients need thromboprophylactic anticoagulation?

AU - Mukerji, Amar Nath

AU - Karachristos, Andreas

AU - Maloo, Manoj

AU - Johnson, David

AU - Jain, Ashokkumar

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Postoperative thromboprophylactic anticoagulation against Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) is standard of care with current evidence-based guidelines. However, majority of liver transplant (LT) patients have thrombocytopenia and/or prolonged INR before surgery. Studies or guidelines regarding role of prophylactic anticoagulation after LT are lacking. There is a need to balance the risk of thrombosis with significant hemorrhage, implying those needing transfusion or return to OR due to bleeding. We conclude that after LT, anticoagulation is not required routinely for DVT/PE prophylaxis. Rather, it is indicated in specific circumstances, chiefly for prophylaxis of hepatic artery thrombosis or portal vein thrombosis in cases with use of grafts, pediatric cases, small size vessels, Budd Chiari syndrome, amongst others.

AB - Postoperative thromboprophylactic anticoagulation against Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) is standard of care with current evidence-based guidelines. However, majority of liver transplant (LT) patients have thrombocytopenia and/or prolonged INR before surgery. Studies or guidelines regarding role of prophylactic anticoagulation after LT are lacking. There is a need to balance the risk of thrombosis with significant hemorrhage, implying those needing transfusion or return to OR due to bleeding. We conclude that after LT, anticoagulation is not required routinely for DVT/PE prophylaxis. Rather, it is indicated in specific circumstances, chiefly for prophylaxis of hepatic artery thrombosis or portal vein thrombosis in cases with use of grafts, pediatric cases, small size vessels, Budd Chiari syndrome, amongst others.

UR - http://www.scopus.com/inward/record.url?scp=84927700901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927700901&partnerID=8YFLogxK

U2 - 10.1177/1076029614538490

DO - 10.1177/1076029614538490

M3 - Article

C2 - 24917126

AN - SCOPUS:84927700901

VL - 20

SP - 673

EP - 677

JO - Clinical and Applied Thrombosis/Hemostasis

JF - Clinical and Applied Thrombosis/Hemostasis

SN - 1076-0296

IS - 7

ER -